About Hertab 250mg Lapatinib IP Tablets
Hertab 250mg Lapatinib IP Tablets stand tall as a superlative and affordable choice in targeted cancer therapy. Powered by the ace ingredient Lapatinib and manufactured with rigorous standards in India, these popular yellowish-orange, oval tablets are trusted for HER2 positive metastatic breast cancer. Each box contains 30 tablets, offering a shelf life of 2 years. Recommended for adults and used in combination with Capecitabine, Hertab is prescribed by physicians and dispensed responsibly by exporters and suppliers. Its Markdown price and towering efficacy make it highly sought after.
Key Applications and Product Features
Hertab 250mg Lapatinib IP Tablets are intended for advanced or metastatic breast cancer, specifically HER2 positive cases. These oral tablets are engineered with a sophisticated machine process ensuring consistent quality. Their primary usage involves targeted therapy, often in combination with Capecitabine. Suitable for adults, each tablet delivers a precise 250 mg dosage per physician's directions. The tablets are packed meticulously in boxes of 30, formulated for easy oral administration and optimized shelf stability.
Sample Availability, Export Markets, and Delivery Process
Hertab 250mg Lapatinib IP Tablets samples can be requested and are ready for swift dispatch. Our main export markets include Asia, Africa, and Eastern Europe, meeting global demand through reliable supply chains. Packing & dispatch protocols ensure tablets arrive securely and swiftly at their destination. Our supply ability matches significant international demand, with products thoroughly packaged to guarantee quality upon arrival. We prioritize careful packing and timely delivery to maintain superlative satisfaction.
FAQ's of Hertab 250mg Lapatinib IP Tablets:
Q: How should Hertab 250mg Lapatinib IP Tablets be administered?
A: Hertab 250mg tablets should be taken orally with water exactly as prescribed by your physician, usually once daily. Follow your doctor's dosage guidelines and do not alter the regimen without medical advice.
Q: What is the primary benefit of using Hertab 250mg Lapatinib IP Tablets?
A: The primary benefit is its targeted inhibition of HER2 receptors in metastatic breast cancer, which helps control disease progression, especially when combined with Capecitabine.
Q: When should Hertab 250mg be considered for therapy?
A: Hertab 250mg is recommended for adults diagnosed with advanced or metastatic HER2 positive breast cancer, particularly as part of a combination therapy with Capecitabine.
Q: Where is Hertab 250mg manufactured and exported from?
A: Hertab 250mg is manufactured in India and is exported to several regions, including Asia, Africa, and Eastern Europe by leading suppliers and distributors.
Q: What storage instructions must be followed for Hertab 250mg tablets?
A: Store Hertab 250mg tablets in a dry place, below 30C, away from moisture and direct sunlight, and out of reach of children for optimal shelf life and efficacy.
Q: Is Hertab 250mg available for sample requests or trial orders?
A: Yes, Hertab 250mg Lapatinib IP Tablets are available for sampling. Contact your supplier or exporter to request a sample, and they will arrange proper packing and prompt dispatch.